Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1EE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,159
Award facts
- Contract value 100% obligated
- $25,158.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,158.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of IMFINZI (durvalumab) 500 mg/10 ml vials. The contract will be completed by January 15, 2026, with performance and delivery taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for global pharmaceutical support to military healthcare systems worldwide.
IMFINZI is an oncology medication used in the treatment of certain cancers, and this procurement supports the Department of Defense's medical supply chain requirements for military and veteran healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates extensive experience delivering a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to defense and civilian government agencies. The company's role as a critical pharmaceutical distributor for federal medical procurement, combined with its established prime vendor status under the DLA Troop Support Medical contract, positions it as a key supplier for meeting military healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FM1EE?
SPE2DR26FM1EE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FM1EE worth?
The government has obligated $25,159 on SPE2DR26FM1EE.
Is contract SPE2DR26FM1EE an order under another contract?
Yes. SPE2DR26FM1EE is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1EE competed?
The extent of competition for SPE2DR26FM1EE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award